Catalyst Wire Dossier Catalyst Wire Dossier

Semaglutide (oral)

semaglutide · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Semaglutide (oral), covering 2014-12-03 to 2017-06-07. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females [Phase 1]

See pricing